http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-520298-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ce868b9e53b7acdb989834eb13b394e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 1998-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b223bc4133aa35befb80a4948aa143d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34ecc271498059cf733d7761eaf0f6f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b14697f1c314005b9caa9fdbbee5e0c0 |
| publicationDate | 2003-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-520298-B |
| titleOfInvention | Oral morphine multiparticulate formulation |
| abstract | An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polymer coat comprised of ammonio methacrylate copolymers in an amount sufficient to achieve therapeutically effective plasma levels of morphine over at least 24 hours in the patient. |
| priorityDate | 1997-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.